Cargando…
292 Fibromyalgianess and Glucocorticoid Persistence Among Patients with Rheumatoid Arthritis
OBJECTIVES/GOALS: Over 30% of patients with rheumatoid arthritis (RA) exhibit fibromyalgianess, a symptom cluster associated with increased pain sensitivity. Up to half of RA patients use oral glucocorticoids (GCs) long-term despite their known, dose-dependent toxicity. We examined the association b...
Autores principales: | Wallace, Beth, Moore, Meriah N., Heisler, Andrew C., Muhammad, Lutfiyya N., Song, Jing, Clauw, Daniel J., Bingham, Clifton O., Bolster, Marcy B., Marder, Wendy, Neogi, Tuhina, Wohlfahrt, Alyssa, Dunlop, Dorothy D., Lee, Yvonne C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209195/ http://dx.doi.org/10.1017/cts.2022.161 |
Ejemplares similares
-
313 Biobehavioral predictors of dose-limiting toxicities of cancer therapy: Identification of areas for preventative intervention
por: Thornton, Clifton P., et al.
Publicado: (2022) -
327 Nociplastic pain and early discontinuation of aromatase inhibitor therapy in breast cancer patients over age 65
por: Joyce, Elizabeth, et al.
Publicado: (2022) -
299 Serum Aldosterone and Urine Electrolytes Dynamics in Response to DASH Diet Intervention
por: Bielopolski, Dana, et al.
Publicado: (2022) -
448 Isolation and identification of bioprospects capable of metabolizing 17-beta-estradiol and 17-alpha-ethinylestradiol using metagenomics and culture-dependent techniques in Puerto Rico
por: Ríos-Velázquez, Carlos, et al.
Publicado: (2022) -
408 In vivo calcium imaging in the medial prefrontal cortex reveals novel site of action for therapeutic effects of Neuromedin U
por: Miller, Sierra N., et al.
Publicado: (2022)